Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan
· Delayed Price · Currency is JPY 2,314.00
+40.00 (1.76%)
Mar 10, 2026, 10:05 AM JST
Rohto Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 513,843 | 505,369 | 676,888 | 631,946 | 421,488 | 336,849 | Upgrade
|
| Market Cap Growth | -8.50% | -25.34% | 7.11% | 49.93% | 25.13% | -0.24% | Upgrade
|
| Enterprise Value | 508,934 | 493,570 | 610,616 | 575,682 | 380,505 | 296,984 | Upgrade
|
| Last Close Price | 2274.00 | 2218.10 | 2904.20 | 2690.13 | 1778.18 | 1407.26 | Upgrade
|
| PE Ratio | 15.30 | 16.30 | 21.88 | 23.96 | 20.05 | 20.12 | Upgrade
|
| Forward PE | 15.48 | 15.19 | 20.08 | 24.15 | 19.94 | 21.85 | Upgrade
|
| PS Ratio | 1.53 | 1.64 | 2.50 | 2.65 | 2.11 | 1.86 | Upgrade
|
| PB Ratio | 1.69 | 1.86 | 2.74 | 2.94 | 2.29 | 2.15 | Upgrade
|
| P/TBV Ratio | 2.49 | 2.48 | 2.86 | 3.16 | 2.49 | 2.27 | Upgrade
|
| P/FCF Ratio | - | 18.16 | 25.77 | 28.15 | 24.82 | 29.84 | Upgrade
|
| P/OCF Ratio | - | 13.69 | 19.77 | 20.43 | 15.47 | 16.84 | Upgrade
|
| PEG Ratio | 4.30 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | Upgrade
|
| EV/Sales Ratio | 1.52 | 1.60 | 2.26 | 2.41 | 1.91 | 1.64 | Upgrade
|
| EV/EBITDA Ratio | 8.95 | 9.56 | 12.50 | 13.93 | 10.61 | 10.38 | Upgrade
|
| EV/EBIT Ratio | 12.60 | 12.83 | 15.20 | 17.17 | 13.50 | 13.58 | Upgrade
|
| EV/FCF Ratio | - | 17.73 | 23.25 | 25.64 | 22.41 | 26.31 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.19 | 0.04 | 0.05 | 0.12 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.92 | 0.97 | 0.21 | 0.28 | 0.60 | 0.28 | Upgrade
|
| Debt / FCF Ratio | - | 1.80 | 0.40 | 0.52 | 1.26 | 0.72 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.10 | -0.32 | -0.32 | -0.28 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.39 | -0.52 | -1.61 | -1.65 | -1.43 | -1.57 | Upgrade
|
| Net Debt / FCF Ratio | - | -0.97 | -3.00 | -3.04 | -3.03 | -3.97 | Upgrade
|
| Asset Turnover | 0.78 | 0.80 | 0.83 | 0.82 | 0.80 | 0.82 | Upgrade
|
| Inventory Turnover | 2.31 | 2.47 | 2.59 | 2.72 | 2.71 | 2.55 | Upgrade
|
| Quick Ratio | 1.35 | 1.55 | 1.82 | 1.75 | 1.74 | 1.79 | Upgrade
|
| Current Ratio | 2.03 | 2.30 | 2.47 | 2.37 | 2.30 | 2.36 | Upgrade
|
| Return on Equity (ROE) | 12.20% | 11.94% | 13.59% | 13.25% | 12.42% | 11.31% | Upgrade
|
| Return on Assets (ROA) | 5.80% | 6.26% | 7.66% | 7.17% | 7.04% | 6.20% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.04% | 13.63% | 19.28% | 18.52% | 17.47% | 14.91% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.40% | 11.80% | 15.50% | 14.60% | 13.90% | 12.90% | Upgrade
|
| Earnings Yield | 6.72% | 6.13% | 4.57% | 4.17% | 4.99% | 4.97% | Upgrade
|
| FCF Yield | - | 5.51% | 3.88% | 3.55% | 4.03% | 3.35% | Upgrade
|
| Dividend Yield | 2.02% | 1.62% | 0.93% | 0.82% | 1.01% | 1.00% | Upgrade
|
| Payout Ratio | - | 22.81% | 17.70% | 17.73% | 16.28% | 17.71% | Upgrade
|
| Buyback Yield / Dilution | -1.58% | -0.04% | 0.00% | 0.00% | - | -0.01% | Upgrade
|
| Total Shareholder Return | 0.44% | 1.58% | 0.93% | 0.82% | 1.01% | 0.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.